Dr. Angela Cano Yuste – Infectious DIseases – Best Researcher Award

Dr. Angela Cano Yuste - Infectious DIseases - Best Researcher Award

Reina Sofia University Hospital/IMIBIC - Spain 

Author Profile 

SCOPUS 

Early academic pursuits 🎓

Angela Cano Yuste embarked on her academic journey at the Universidad de Córdoba, where she earned her degree in Medicine and Surgery in 2005. Driven by a passion for healthcare and community service, she further specialized in Family and Community Medicine at the Reina Sofia University Hospital, completing her training in 2010. Her quest for knowledge led her to pursue a Master’s in Research Methodology at the Universidad de Córdoba, which she completed in 2017. Angela’s academic achievements culminated in earning a Ph.D. in Medicine from the Biomedicine Program at the Universidad de Córdoba in 2023, solidifying her expertise in the field.

Professional endeavors 👨‍🌾

Angela’s professional career is marked by her dedication to both clinical practice and research. She began her career as an Emergency Physician at the Hospital de Montilla, serving from 2010 to 2018. In 2015, she joined FISEVI-FIBICO as an Investigator in the Infectious Diseases department, where she contributed significantly until 2021. Currently, Angela serves as a Specialist in Infectious Diseases at the Hospital Universitario Reina Sofia, a position she has held since 2021. Her role involves addressing complex infectious diseases, where she applies her extensive knowledge and experience to improve patient outcomes.

Contributions and research focus đź”§

Angela’s research is deeply rooted in the study and management of infectious diseases. Her work has primarily focused on complicated infections, including hospital-acquired pneumonia and Infectious DIseases infections caused by carbapenem-resistant Enterobacteriaceae. Angela has been instrumental as a Principal Investigator in several clinical trials, including those focused on complicated intra-abdominal infections in septic patients and interventional trials targeting hospital-acquired pneumonia and complicated infections. Her research efforts aim to advance the understanding and treatment of these critical conditions, contributing to better clinical practices and patient care.

Accolades and recognition 🌟

Throughout her career, Angela has garnered respect and recognition for her contributions to the field of infectious diseases. Her leadership in clinical trials and her commitment to advancing Infectious DIseases medical research have earned her accolades within the scientific and medical communities. Angela’s work in high-impact clinical studies reflects her dedication to improving healthcare outcomes through rigorous research and evidence-based practice.

Impact and influence 🌍

Angela’s impact extends beyond her immediate clinical and research responsibilities. Her work in infectious diseases has influenced treatment protocols and contributed to the global Infectious DIseases understanding of managing complex infections. Her research findings have helped shape strategies for combating antibiotic-resistant bacteria and improving patient care in hospital settings. Angela’s influence is evident in her contributions to medical literature and her role in guiding future research directions in infectious diseases.

Legacy and future contributions 🔄

Angela Cano Yuste’s legacy lies in her unwavering commitment to medical excellence and research innovation. As she continues her work at the Hospital Universitario Reina Sofia, Angela remains at the forefront of infectious disease research and clinical practice. Her future contributions are poised to further advance the field, particularly in developing new treatment protocols and managing emerging infectious threats. Angela’s dedication ensures that her impact will resonate within the medical community for years to come, inspiring future generations of healthcare professionals..

Notable publications 

  • Title: Invasive aspergillosis in liver transplant recipients in the current era
    Authors: Kimura, M., Rinaldi, M., Kothari, S., Selzner, N., Husain, S.
    Journal: American Journal of Transplantation, 2024, 24(11), pp. 2092–2107
  • Title: Long-Term Clinical and Ecological Impact of an Antimicrobial Stewardship Program on the Incidence of Carbapenem-Resistant Klebsiella pneumoniae Infections in a High-Endemic Hospital
    Authors: López-Viñau, T., Muñoz-Rosa, M., Ruiz-Lara, L.M., Martínez-Martínez, L., Torre-Cisneros, J.
    Journal: Antibiotics, 2024, 13(9), 792
  • Title: Risk factors for bloodstream infections due to carbapenem-resistant Enterobacterales: a nested case-control-control study
    Authors: Zhou, H., Buetti, N., Pérez-Galera, S., Ozakin, C., Layunta-Acero, R.
    Journal: Journal of Antimicrobial Chemotherapy, 2024, 79(9), pp. 2132–2141
  • Title: Efficacy and safety of a structured de-escalation from antipseudomonal β-lactams in bloodstream infections due to Enterobacterales (SIMPLIFY): an open-label, multicentre, randomised trial
    Authors: López-Cortés, L.E., Delgado-Valverde, M., Moreno-Mellado, E., Díaz-López, M.D., Paño, J.R.
    Journal: The Lancet Infectious Diseases, 2024, 24(4), pp. 375–385
  • Title: Attributable mortality of infections caused by carbapenem-resistant Enterobacterales: results from a prospective, multinational case-control-control matched cohorts study (EURECA)
    Authors: Paniagua-García, M., Bravo-Ferrer, J.M., Pérez-Galera, S., Sahin, A., Akalin, H.
    Journal: Clinical Microbiology and Infection, 2024, 30(2), pp. 223–230

Prof. Mingqian fang – Immunology & Hematology – Women Researcher Award

Prof. Mingqian fang - Immunology & Hematology - Women Researcher Award

Kunming Institute of Zoology, Chinese Academy of Sciences - Zimbabwe

Author Profile

ORCID 

Early academic pursuits 🎓

Mingqian fang embarked on his academic journey with a keen interest in biology and medical sciences, eventually specializing in the study of disease pathogenesis. his early work centered on understanding how infections and inflammatory responses influence mental health, particularly focusing on stress-induced depression. his educational background laid a strong foundation for his future research in both neuroscience and cardiovascular diseases. as a professor at the kunming institute of zoology, chinese academy of sciences, he has consistently contributed to groundbreaking research.

Professional endeavors 🏢

As a professor at the kunming institute of zoology, mingqian has dedicated his career to exploring the connections between stress, depression, and physiological responses to infections. his research has not only deepened our understanding of how stress exacerbates mental health disorders, but has also opened pathways to developing effective treatments for both depression and cardiovascular diseases. his expertise extends to studying natural toxin peptides, with particular focus on their biomedical applications.

Contributions and research focus 🔬

Mingqian’s primary research areas include the pathogenesis of diseases like depression under stressful stimuli, such as infections and inflammation, and the Immunology & Hematology development of innovative drugs to treat these conditions. his notable work includes the discovery of how lipopolysaccharide-binding protein expression is increased by stress, promoting depressive symptoms by inhibiting monoamine synthesis. he has also explored the role of bat-derived peptides and how they impact neuroinflammation, contributing significantly to the understanding of the body's immune response to various stressors.

Accolades and recognition 🏅

Mingqian fang’s research has been widely recognized in the scientific community, with publications in high-impact journals such as immunity and pnas. his works have earned accolades due to their novel insights into how biological systems respond to stress and disease. his research in immune responses and toxin peptides has Immunology & Hematology been acknowledged globally, with his papers being published in top-tier journals with high impact factors, demonstrating the importance and quality of his findings.

Impact and influence 🌍

Mingqian’s research has had a far-reaching impact on both neuroscience and cardiovascular medicine. by linking mental health issues like depression to biological processes such as inflammation, he has paved the way for new treatment methodologies. his work on natural toxins also holds promise for creating innovative drugs Immunology & Hematology that could target specific disease mechanisms, further influencing the pharmaceutical industry and biomedical research. his influence spans across multiple fields, combining neuroscience, immunology, and pharmacology.

Legacy and future contributions đź”®

Mingqian fang’s ongoing work ensures that his legacy in the scientific world continues to grow. his pioneering research on stress-related depression and cardiovascular conditions is laying the groundwork for future innovations in drug development. by bridging the gap between neuroscience and immunology, his research will likely inspire further interdisciplinary studies aimed at improving human health. his work on bat-derived peptides, in particular, opens exciting possibilities for novel therapies.

Notable Publications 

  • Title: The Price of P2X7R Freedom is Neuroinflammation
    Authors: Fang M, Lai R
    Journal: Immunity
    Date: March 2024
    DOI: 10.1016/j.immuni.2024.02.009
  • Title: Transferrin Is Up-Regulated by Microbes and Acts as a Negative Regulator of Immunity to Induce Intestinal Immunotolerance
    Authors: Tang X, Fang M, Cheng R, Niu J, Huang X, Xu K, Wang G, Sun Y, Liao Z, Zhang Z et al.
    Journal: Research (Washington, D.C.)
    Date: January 2024
    DOI: 10.34133/research.0301
  • Title: Lipopolysaccharide-Binding Protein Expression is Increased by Stress and Inhibits Monoamine Synthesis to Promote Depressive Symptoms
    Authors: Fang M, Li Y, Liao Z, Wang G, Cao Q, Li Y, Duan Y, Han Y, Deng X, Wu F et al.
    Journal: Immunity
    Date: February 2023
    DOI: 10.1016/j.immuni.2023.02.002
  • Title: An Undefined Cystatin CsCPI1 from Tea Plant Camellia sinensis Harbors Antithrombotic Activity
    Authors: Fang M, Cha JH, Wang HC, Ye P, Chen B, Chen M, Yang WH, Yan X
    Journal: Biomedicine & Pharmacotherapy
    Date: January 2023
    DOI: 10.1016/j.biopha.2023.114285
  • Title: Hypoxia and Low Temperature Upregulate Transferrin to Induce Hypercoagulability at High Altitude
    Authors: Li M, Tang X, Liao Z, Shen C, Cheng R, Fang M, Wang G, Li Y, Tang S, Xie L et al.
    Journal: Blood
    Date: November 2022
    DOI: 10.1182/blood.2022016410